The paradox that NKT cells both promoted and suppressed tumor immunity was resolved when it was found that type II NKT cells, still present in Jα18−/− mice but absent in CD1d−/− mice, were sufficient to suppress (24). This evidence concerns the gene CD1D and neoplasm.